BAX Baxter International Inc.

Baxter to Present at the 28th Annual Piper Jaffray Healthcare Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--

Baxter International Inc. (NYSE:BAX) will present at the 28th Annual Piper Jaffray Healthcare Conference on Tuesday, November 29, 2016 in New York City. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 9:30 a.m. Eastern Time.

The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through January 28, 2017.

Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

EN
08/11/2016

Underlying

BAXBaxter International Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Baxter International Inc.

EUR 152.87
BAX Baxter Internat...

Moody's Ratings assigns Baa3 rating to Baxter's senior notes; outlook ...

Moody's Ratings (Moody's) assigned a Baa3 rating to the proposed new senior unsecured notes issuance of Baxter International Inc. (Baxter). At the same time, we assigned a (P)Baa3 rating to Baxter's senior unsecured shelf registration. There are no changes to Baxter's existing ratings including the ...

BAX BAXTER INTERNATIONAL INC.
11/19/25 November 19, 2025 1 EN
EUR 152.87
BAX Baxter Internat...

Baxter International Inc.: Update following downgrade to Baa3

Our credit view of this issuer reflects its elevated financial leverage, with delays in reaching previously stated deleveraging targets.

BAX BAXTER INTERNATIONAL INC.
11/18/25 November 18, 2025 1 EN
EUR 152.87
BAX Baxter Internat...

Moody's Ratings downgrades Baxter to Baa3/P-3; outlook is stable

Moody's Ratings (Moody's) downgraded the ratings of Baxter International Inc. (Baxter) including the senior unsecured ratings to Baa3 from Baa2 and the commercial paper rating to Prime-3 from Prime-2. The outlook is stable. Previously, the ratings were on review for downgrade. This action concludes ...

BAX BAXTER INTERNATIONAL INC.
11/13/25 November 13, 2025 1 EN
EUR 152.87
BAX Baxter Internat...

Moody's Ratings reviews Baxter's Baa2/P-2 ratings for downgrade

Moody's Ratings (Moody's) placed the ratings of Baxter International Inc. (Baxter) on review for downgrade. The ratings placed on review include the Baa2 senior unsecured ratings and Prime-2 commercial paper rating. Previously, the outlook was negative. The review is prompted by operating pressure...

BAX BAXTER INTERNATIONAL INC.
11/04/25 November 4, 2025 1 EN
BAX Baxter Internat...

Moody's Ratings affirms Baxter at Baa2; revises outlook to negative fr...

Moody's Ratings (Moody's) affirmed Baxter International Inc.'s (Baxter) ratings, including its Baa2 senior unsecured ratings and Prime-2 commercial paper rating. At the same time, we revised the outlook to negative from stable. The ratings affirmation considers Baxter's good scale and diversity as...

BAX BAXTER INTERNATIONAL INC.
08/07/25 August 7, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch